(Q37763104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Recently identified and potential targets for colon cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Michael A Lea

series ordinal

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

993-1002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy for operable and advanced colorectal cancer.

4 February 2020

cites work

1 reference

Adjuvant therapy for colon cancer: present and perspectives

21 January 2018

1 reference

Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer

21 January 2018

1 reference

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

Chemotherapy of colorectal cancer

21 January 2018

1 reference

Targeted biotherapy: a revolution in the management of patients with colorectal cancer?

21 January 2018

1 reference

Chemotherapy options and outcomes in older adult patients with colorectal cancer

21 January 2018

1 reference

Evolving treatment of advanced colon cancer.

21 January 2018

1 reference

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

21 January 2018

1 reference

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

21 January 2018

1 reference

Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance.

21 January 2018

1 reference

5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells

21 January 2018

1 reference

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells.

21 January 2018

1 reference

A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells

21 January 2018

1 reference

The potential role and application of PARP inhibitors in cancer treatment

21 January 2018

1 reference

Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

21 January 2018

1 reference

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

21 January 2018

1 reference

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

21 January 2018

1 reference

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer

21 January 2018

1 reference

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial

21 January 2018

1 reference

Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers

21 January 2018

1 reference

Targeted nanomaterials for radiotherapy

21 January 2018

1 reference

The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial development

21 January 2018

1 reference

The antiangiogenic effect of thalidomide on occult liver metastases: an in vivo study in mice

21 January 2018

1 reference

21 January 2018

Eicosanoids and cancer

1 reference

NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer

21 January 2018

1 reference

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

21 January 2018

1 reference

Epigenetic regulation of microRNA expression in colorectal cancer

21 January 2018

1 reference

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

21 January 2018

1 reference

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

21 January 2018

1 reference

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

21 January 2018

1 reference

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel

21 January 2018

1 reference

HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells

21 January 2018

1 reference

Tumor cell differentiation by butyrate and environmental stress

21 January 2018

1 reference

Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent

21 January 2018

1 reference

Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms

21 January 2018

1 reference

A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer

21 January 2018

1 reference

A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy

21 January 2018

1 reference

Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models

21 January 2018

1 reference

Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities

21 January 2018

1 reference

Three DNA methylation epigenotypes in human colorectal cancer

21 January 2018

1 reference

HDAC family: What are the cancer relevant targets?

21 January 2018

1 reference

Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines

21 January 2018

1 reference

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2

21 January 2018

1 reference

Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.

21 January 2018

1 reference

Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications

21 January 2018

1 reference

Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft

21 January 2018

1 reference

APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.

21 January 2018

1 reference

On the Origin of Cancer Cells

21 January 2018

1 reference

Energy boost: the Warburg effect returns in a new theory of cancer

21 January 2018

1 reference

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

21 January 2018

1 reference

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells

21 January 2018

1 reference

Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate

21 January 2018

1 reference

Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

21 January 2018

1 reference

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.10.53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528236%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference